₹21.19
▼ -0.89 -4.03%
As of 23 Oct 2026 · delayed
NSE Listed
Syncom Formulations (India) Ltd. (SYNCOMF)
Volume: 1,49,43,853Avg Vol 1W: 1,41,68,453.2Avg Vol 1M: 3,53,93,26552W Range:₹10.21₹27.49
Key Ratios
Checked 21h agoMarket Cap₹1,992 Cr
Current Price₹21.19
Previous Close₹22.08
High / Low (52w)₹27.49 / ₹10.21
Volume1,49,43,853
Avg Vol (1W)1,41,68,453.2
Avg Vol (1M)3,53,93,265
Stock P/E31.63
Book Value₹3.62
Dividend Yield—
ROE15.6%
ROA—
Revenue (TTM)₹482 Cr
Revenue Growth—
Profit Margin—
Total Debt₹0 Cr
Shares Outstanding—
Face Value₹1
EPS (TTM)₹0.52
P/B4.54
Debt / Equity0.12
50 DMA₹20.1
200 DMA₹15.1
Day change-4.03%
Price Chart
₹21.19▲ 27.42% · 1Y
2025-10-272026-10-23
20-day avg volume: 3.5Cr shares
Pros
- Healthy return on equity of 15.6%.
- Company is almost debt-free.
Cons
- Revenue fell 16% YoY.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹102 Cr | ₹128 Cr | ₹149 Cr | ₹117 Cr | ₹122 Cr | ₹115 Cr | ₹135 Cr | ₹126 Cr |
| EBITDA | ₹15 Cr | ₹17 Cr | ₹23 Cr | ₹21 Cr | ₹22 Cr | ₹25 Cr | ₹34 Cr | ₹33 Cr |
| Net Profit | ₹11 Cr | ₹13 Cr | ₹18 Cr | ₹16 Cr | ₹17 Cr | ₹19 Cr | ₹25 Cr | ₹25 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹148 Cr | ₹482 Cr | ₹117 Cr | ₹121 Cr | ₹115 Cr | ₹134 Cr | ₹521 Cr | ₹125 Cr |
| EBITDA | ₹23 Cr | ₹66 Cr | ₹20 Cr | ₹23 Cr | ₹25 Cr | ₹33 Cr | ₹102 Cr | ₹32 Cr |
| Net Profit | ₹18 Cr | ₹49 Cr | ₹16 Cr | ₹17 Cr | ₹19 Cr | ₹25 Cr | ₹76 Cr | ₹25 Cr |
| EPS | — | 0.53 | — | — | — | — | 0.81 | — |
Balance Sheet
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹138 Cr | ₹175 Cr | ₹180 Cr | ₹308 Cr | ₹378 Cr | ₹405 Cr | ₹413 Cr | ₹534 Cr |
| Total Liabilities | ₹37 Cr | ₹67 Cr | ₹63 Cr | ₹86 Cr | ₹122 Cr | ₹117 Cr | ₹71 Cr | ₹119 Cr |
| Equity | ₹100 Cr | ₹109 Cr | ₹117 Cr | ₹222 Cr | ₹256 Cr | ₹288 Cr | ₹342 Cr | ₹415 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹7 Cr | ₹30 Cr | ₹18 Cr | ₹23 Cr | ₹17 Cr | ₹2 Cr | ₹38 Cr | ₹81 Cr |
| Investing | ₹1 Cr | ₹-23 Cr | ₹-18 Cr | ₹-27 Cr | ₹-45 Cr | ₹83 Cr | ₹-18 Cr | ₹-51 Cr |
| Financing | ₹1 Cr | ₹-2 Cr | ₹5 Cr | ₹8 Cr | ₹35 Cr | ₹-15 Cr | ₹-68 Cr | ₹-3 Cr |
| Free Cash Flow | ₹3 Cr | ₹26 Cr | ₹5 Cr | ₹23 Cr | ₹17 Cr | ₹2 Cr | ₹38 Cr | ₹81 Cr |
Shareholding
Promoter 50.57% Institutions 2.23% Public 47.2%
Efficiency & Working Capital
ROCE24.5%
Interest Coverage88.2
Dividend Payout—
Debtor Days82 d
Inventory Days47 d
Payable Days56 d
Cash Conversion Cycle74 d
Working Capital Days129 d
Shareholding Details
As of 2026-09-30
Promoter50.6%
FII2.2%
DII0%
Institutions2.2%
Public47.2%
Promoter Pledge0%
No. of Shareholders4,18,465
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 50.6% | 50.6% | 50.6% | 50.6% | 50.6% | 50.6% | 50.6% | 50.6% | 50.6% | 50.6% | 50.6% | 50.6% |
| FIIs | 0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.4% | 0.1% | 0.3% | 0.2% | 0.3% | 2.2% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 49.4% | 49.4% | 49.3% | 49.3% | 49.3% | 49.3% | 49% | 49.3% | 49.2% | 49.2% | 49.1% | 47.2% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 2,89,982 | 3,25,761 | 3,76,530 | 4,69,242 | 4,89,520 | 4,84,529 | 4,71,066 | 4,57,364 | 4,42,280 | 4,31,690 | 4,22,114 | 4,18,465 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Kedarmal Shankarlal Bankda | Shareholding of Promoter and Promoter Group | 12.4% | 11.69 Cr |
| Vijay Shankarlal Bankda | Shareholding of Promoter and Promoter Group | 10.5% | 9.86 Cr |
| Paradise Vyapar Private Limited | Shareholding of Promoter and Promoter Group | 5% | 4.72 Cr |
| Ankit Bankda | Shareholding of Promoter and Promoter Group | 5% | 4.69 Cr |
| Asha Vijay Bankda | Shareholding of Promoter and Promoter Group | 4.9% | 4.61 Cr |
| Vimla Bankda | Shareholding of Promoter and Promoter Group | 4.3% | 4.01 Cr |
| Strand Developers Pvt Ltd | Shareholding of Promoter and Promoter Group | 3.8% | 3.59 Cr |
| Vijay Bankda Huf | Shareholding of Promoter and Promoter Group | 1.3% | 1.21 Cr |
| Payal Ankur Bankda | Shareholding of Promoter and Promoter Group | 1.3% | 1.17 Cr |
| Kedarmal Shankarlal Bankda Huf | Shareholding of Promoter and Promoter Group | 1.1% | 1.05 Cr |
| Sulabh Rahul Bankda | Shareholding of Promoter and Promoter Group | 1% | 93,00,100 |
| Rahul Bankda | Shareholding of Promoter and Promoter Group | 0% | 1,69,500 |
| Ankur Vijay Bankda | Shareholding of Promoter and Promoter Group | 0% | 63,900 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Ruchi Jindal | Independent Non Exe. Director | 2025 |
| Ritesh Kumar Lunkad | Independent Non Exe. Director | 2025 |
| Ankit Jain | Independent Non Exe. Director | 2025 |
| ANKIT KEDARMAL BANKDA | Chairman / Executive Director / WTD | 2025 |
| Vaishali Agrawal | Company Sec. & Compli. Officer | 2025 |
| Rahul Vijay Bankda | Managing Director &Addtnl Dir. | 2025 |
| Rinki Ankit Bankda | WTD & Additional Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceutical Drugs & Formulations | ₹513 Cr | 99.1% |
| Trading of Commodities | ₹1 Cr | 0.2% |
| Renting of Property | ₹4 Cr | 0.7% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| In India | ₹114 Cr | 22% |
| Outside India | ₹404 Cr | 78% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹1 | 95 | 94 | 94 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-09-23 | Dividend | — |
| dividend | 2026-09-23 | ₹0.1 (10%) | Final |
| forthcoming | 2026-08-11 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 5 | 16 | 25 |
| 2026 | 0 | 0 | 0 | 2 | 1 | 6 |
| 2026 | 0 | 0 | 0 | 3 | 0 | 4 |
Insider / Designated-Person Trades
6 recent disclosure(s)
Shankarlal Bankda HUFDisposal · 27,31,470
Kedarmal Shankarlal BankdaAcquisition · 27,31,470
Asha BankdaAcquisition · 1,35,00,000
Vimla BankdaAcquisition · 4,00,47,000
Kedarmal Shankarlal BankdaAcquisition · 2,40,00,000
Asha Vijay BankdaAcquisition · 3,25,00,000
Company Information
Incorporated1988
ChairmanANKIT KEDARMAL BANKDA
AuditorSanjay Mehta & Associates
Investor Email[email protected]; [email protected]
📍 7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd, Mumbai, Maharashtra, 400093
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Swiggy LimitedSwiss Military Consumer Goods Ltd.Sterling & Wilson Renewable Energy Ltd.Sylvan Plyboard (India) LimitedSymbiotec Pharmalab Ltd.Symphony LimitedSyngene International Ltd.Synoptics Technologies LimitedSyrma SGS Technology Ltd.Systango Technologies Ltd.Systematix Corporate Services Ltd.TaaL Tech Ltd.All “S” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search